Standout Papers
- Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. (1993)
Citation Impact
Citing Papers
Clinical exercise testing with reference to lung diseases: indications, standardization and interpretation strategies. ERS Task Force on Standardization of Clinical Exercise Testing. European Respiratory Society
1997
Reference values of Forced Expiratory Volumes and pulmonary flows in 3–6 year children: a cross-sectional study
2007
Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers
2002
Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial
2003
Normal Spirometric Reference Values for Omani Adults
2009
Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome
2009
The effect of ozone exposure on allergen responsiveness in subjects with asthma or rhinitis.
1996
Idiopathic pulmonary fibrosis
2017 Standout
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
2010 Standout
Interleukin-18 in induced sputum: Association with lung function in chronic obstructive pulmonary disease
2009
Age- and height-based prediction bias in spirometry reference equations
2011
Matrix Metalloproteinases in Tuberculosis-Immune Reconstitution Inflammatory Syndrome and Impaired Lung Function Among Advanced HIV/TB Co-infected Patients Initiating Antiretroviral Therapy
2015 StandoutNobel
Rheumatoid arthritis
2016 Standout
Cystic fibrosis
2016 Standout
Effect of Pharmacotherapy on Rate of Decline of Lung Function in Chronic Obstructive Pulmonary Disease
2008
Decline of FEV1 by age and smoking status: facts, figures, and fallacies
1997
Reference equations for lung function screening of healthy never-smoking adults aged 18–80 years
2007
A randomised controlled comparison of tiotropium and ipratropium in the treatment of chronic obstructive pulmonary disease
2000
Maintenance therapy with budesonide and formoterol in chronicobstructive pulmonary disease
2003
On the causes of lung hyperinflation during bronchoconstriction
1997
Diagnostic Spirometry in Primary Care: Proposed standards for general practice compliant with American Thoracic Society and European Respiratory Society recommendations. A General Practice Airways Group (GPIAG)1 document, in association with the Association for Respiratory Technology & Physiology (ARTP)2 and Education for Health3 1www.gpiag.org 2 www.artp.org 3 www.educationforhealth.org.uk
2009
Transforming growth factor-beta1 in sarcoidosis
1998
Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD
2004
An epidemic of silicosis among former denim sandblasters
2008
Deposition, Retention, and Translocation of Ultrafine Particles from the Central Airways and Lung Periphery
2008
Using Pedometers to Increase Physical Activity and Improve Health
2007 Standout
Rapid translocation of nanoparticles from the lung airspaces to the body
2010 StandoutNobel
Cough and Sputum Production Are Associated With Frequent Exacerbations and Hospitalizations in COPD Subjects
2008
Standardisation of spirometry
2005 Standout
Office Spirometry for Lung Health Assessment in Adults
2000
Vital capacities in acute and chronic airway obstruction: dependence on flow and volume histories
1997
Assessing the Reversibility of Airway Obstruction
1998
Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample
2006
Complex networks orchestrate epithelial–mesenchymal transitions
2006 Standout
Tiotropium in Asthma Poorly Controlled with Standard Combination Therapy
2012
Characterisation of COPD heterogeneity in the ECLIPSE cohort
2010
Peak expiratory flow and the resistance of the mini-wright peak flow meter
1996
Cost-effectiveness of self-management in asthmatics: a 1-yr follow-up randomized, controlled trial
2001
Effect of Inhaled Formoterol and Budesonide on Exacerbations of Asthma
1997 Standout
Primary open-angle glaucoma
2004 Standout
Sarcoidosis
2013 Standout
Functions of natural killer cells
2008 Standout
Asthma
2017 Standout
References values for forced spirometry. Group of the European Community Respiratory Health Survey
1998
Comparison of a Combination of Tiotropium Plus Formoterol to Salmeterol Plus Fluticasone in Moderate COPD
2008
Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease
1999 Standout
General considerations for lung function testing
2005 Standout
Bronchodilator reversibility testing in chronic obstructive pulmonary disease
2003
Physical Activity Is the Strongest Predictor of All-Cause Mortality in Patients With COPD
2011
Interpretative strategies for lung function tests
2005 Standout
Air pollution and health
2002 Standout
Asthma
2001 Standout
Inflammatory activity assessment by F18 FDG-PET/CT in persistent symptomatic sarcoidosis
2011
Patient Self-management of Chronic Disease in Primary Care
2002 Standout
Underdiagnosis of myocardial infarction in COPD – Cardiac Infarction Injury Score (CIIS) in patients hospitalised for COPD exacerbation
2008
Spirometric Reference Values in 5 Large Latin American Cities for Subjects Aged 40 Years or Over
2006
Severe Exacerbations and Decline in Lung Function in Asthma
2008
The effects of patient education in COPD in a 1-year follow-up randomised, controlled trial
2003
Improved Criterion for Assessing Lung Function Reversibility
2015
Standardisation of the measurement of lung volumes
2005 Standout
Clinician’s Guide to Cardiopulmonary Exercise Testing in Adults
2010 Standout
Influence of secular trends and sample size on reference equations for lung function tests
2010
Available ventilation monitoring methods during pre-hospital cardiopulmonary resuscitation
2006
Is There an Added Value of Cardiopulmonary Exercise Testing in Sarcoidosis Patients?
2012
Asthma phenotypes: the evolution from clinical to molecular approaches
2012 Standout
Population impact of different definitions of airway obstruction
2003
Long-term Outcome after Pulmonary Endarterectomy
2008
Multi-ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations
2012 Standout
Improving Primary Care for Patients With Chronic Illness
2002 Standout
Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
2012 Standout
Multiple-breath nitrogen washout techniques: including measurements with patients on ventilators
1997
One-year cost-effectiveness of tiotropiumversusipratropium to treat chronic obstructive pulmonary disease
2004
Quality of Cardiopulmonary Resuscitation During Out-of-Hospital Cardiac Arrest
2005 Standout
Signs of immune activation and local inflammation are present in the bronchial tissue of patients with untreated early rheumatoid arthritis
2015
Bronchodilator Response in FVC Is Larger and More Relevant Than in FEV1 in Severe Airflow Obstruction
2016
Spirometer Calibration Checks
2007
Changes in the FEV1/FVC ratio during childhood and adolescence: an intercontinental study
2010
Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium
2002
Diffusion capacity and haemodynamics in primary and chronic thromboembolic pulmonary hypertension
2000
Extending the simple linear regression model to account for correlated responses: An introduction to generalized estimating equations and multi-level mixed modelling
1998
Association of Health Literacy With Diabetes Outcomes
2002 Standout
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
2007 Standout
Idiopathic pulmonary fibrosis
2011 Standout
Interpreting Lung Function Data Using 80% Predicted and Fixed Thresholds Misclassifies More Than 20% of Patients
2010
Interventions to Enhance Patient Adherence to Medication Prescriptions
2002 Standout
Sarcoidosis
2007 Standout
Underdiagnosis of asthma: is the doctor or the patient to blame? The DIMCA project
2000
Multiple breath helium dilution measurement of lung volumes in adults
1998
International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study
2007 Standout
Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials
2009
The EPICure study: Comparison of pediatric spirometry in community and laboratory settings
2008
Near‐fatal asthma phenotype in the ENFUMOSA Cohort
2007
The effects of a lifestyle physical activity counseling program with feedback of a pedometer during pulmonary rehabilitation in patients with COPD: A pilot study
2006
Global burden of COPD: risk factors, prevalence, and future trends
2007 Standout
Characterisation of natural killer cells and CD56+ T-cells in sarcoidosis patients
2005
Clinical Features Associated with a Delayed Diagnosis of Cystic Fibrosis
2000
A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease
2008 Standout
Silicosis
2012 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2001 Standout
Peak Expiratory Flow Profiles Delivered by Pump Systems
2000
Post-Bronchodilator Spirometry Reference Values in Adults and Implications for Disease Management
2006
One Year Treatment with Salmeterol Compared with Beclomethasone in Children with Asthma
1997
Redefining End of Test (EOT) Criteria for Pulmonary Function Testing in Children
1997
Sex-Specific Manifestations of Löfgren's Syndrome
2006
Quality Control for Spirometry in Preschool Children with and without Lung Disease
2004
The Effect of Repeated Ozone Exposures on Inflammatory Markers in Bronchoalveolar Lavage Fluid and Mucosal Biopsies
2000
Repeatability of Spirometry in 18,000 Adult Patients
2003
Predictive Factors of Hospitalization for Acute Exacerbation in a Series of 64 Patients with Chronic Obstructive Pulmonary Disease
1999
Standardization of Spirometry 2019 Update. An Official American Thoracic Society and European Respiratory Society Technical Statement
2019 Standout
“Refractory” Eosinophilic Airway Inflammation in Severe Asthma
2004
The Rise and Dwell Time for Peak Expiratory Flow in Patients with and without Airflow Limitation
1998
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
How Does Patient Education and Self-management among Asthmatics and Patients with Chronic Obstructive Pulmonary Disease Affect Medication?
1999
Effect of Edentulism on Spirometric Tests
2001
Quality of Life Assessment after Patient Education in a Randomized Controlled Study on Asthma and Chronic Obstructive Pulmonary Disease
1999
Effect of Formaldehyde on Asthmatic Response to Inhaled Allergen Challenge
2006
Lung Injury on Antiretroviral Therapy in Adults With Human Immunodeficiency Virus/Tuberculosis
2019 StandoutNobel
Spirometric Standards and Patient Characteristics: An Exploratory Study of Factors Affecting Fulfillment in Routine Clinical Practice
2014
Smokers with airway obstruction are more likely to quit smoking
2006
Medical treatment of glaucoma--a reappraisal of the risks.
1996
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Peak expiratory flow: conclusions and recommendations of a Working Party of the European Respiratory Society.
1997
A Common NLRC4 Gene Variant Associates With Inflammation and Pulmonary Function in Human Immunodeficiency Virus and Tuberculosis
2019 StandoutNobel
Lung volumes and forced ventilatory flows
1993 Standout
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
The Asthma Epidemic
2006 Standout
Mid term effects of pulmonary thromboendarterectomy on clinical and cardiopulmonary function status
2002
Formaldehyde in the Indoor Environment
2010 Standout
Chronic Thromboembolic Pulmonary Hypertension
2006 Standout
Size distribution of exhaled particles in the range from 0.01 to 2.0μm
2010
Lung function in healthy never smoking adults: reference values and lower limits of normal of a Swiss population.
1996
Peak flowmeter resistance decreases peak expiratory flow in subjects with COPD
2000
Airborne transmission of respiratory viruses
2021 StandoutScience
Reproducibility of lung volume measurements
1998
Forced spirometry reference values for Norwegian adults: the Bronchial Obstruction in Nord-Trøndelag study
2001
Valores de referencia espirométrica en 5 grandes ciudades de Latinoamérica para sujetos de 40 o más años de edad
2006
Works of Pedersen Of being referenced
A device for evaluation of flow recording equipment.
1984
[Method related differences in vital capacity].
1983
Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society.
1993 Standout
The Peak Flow Working Group: the characteristics and calibration of devices for recording peak expiratory flow.
1997